X

Astrazeneca Pharma India Ltd Q1FY24; 170% rise in Profits

AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products.

Financial Results:

Astrazeneca Pharma India Ltd reported Revenues for Q1FY24 of ₹295.00 Crores up from ₹232.00 Crore year on year, a rise of 27.16%.

Total Expenses for Q1FY24 of ₹232.00 Crores up from ₹209.00 Crores year on year, a rise of 11.0%.

Consolidated Net Profit of ₹54.00 Crores up 170.0% from ₹20.00 Crores in the same quarter of the previous year.

The Earnings per Share is ₹21.54, up 167.25% from ₹8.06 in the same quarter of the previous year.

*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.

*The presented data is automatically generated. It may occasionally generate incorrect information.

Related Post